E. Gale

Diabetologia · 2002–2010

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from E. Gale's perspective

Ordered by how strongly the researchers E. Gale trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Metformin and reduced risk of cancer in diabetic patients (British medical journal)
  2. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. (Cancer Research)
  3. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin (Diabetes Care)
  4. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. (Journal of the National Cancer Institute)
  5. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  6. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
  7. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American… (Circulation)
  8. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
  9. The metabolic syndrome: time for a critical appraisal (Diabetologia)
  10. Diabetes mellitus and risk of breast cancer: A meta‐analysis (International Journal of Cancer)

Their papers